PCRX Stock Alert: Halper Sadeh LLC is Investigating Whether Pacira BioSciences, Inc. is Obtaining a Fair Price for its Shareholders

$PCRXPress releaseOct 8, 2026, 8:36 AM ETRead the release

Halper Sadeh LLC, an investor rights law firm, is investigating whether Pacira BioSciences' $36.50-per-share cash sale to Viatris fairly compensates shareholders. The firm claims the deal may involve insider benefits, limits on competing offers, and disclosure or fiduciary-duty concerns by Pacira's board.

Key figures

Offering Price: 36.5
Deal price: $36.50 per share in cash

AI analysis

Red flags2 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.